Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Apr;69(3):E16-E18.

PURL: Aspirin, Yes, for at-risk elderly-but what about the healthy elderly?

Cleveland Piggott  1 , Corey Lyon  1
Affiliations
Comment

PURL: Aspirin, Yes, for at-risk elderly-but what about the healthy elderly?

Cleveland Piggott et al. J Fam Pract. 2020 Apr.

Abstract

This study paints a decidedly different picture as to what role-if any-aspirin can play in the primary prevention of CVD for older adults.

PubMed Disclaimer

Comment on

  • Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly.
    McNeil JJ, Wolfe R, Woods RL, Tonkin AM, Donnan GA, Nelson MR, Reid CM, Lockery JE, Kirpach B, Storey E, Shah RC, Williamson JD, Margolis KL, Ernst ME, Abhayaratna WP, Stocks N, Fitzgerald SM, Orchard SG, Trevaks RE, Beilin LJ, Johnston CI, Ryan J, Radziszewska B, Jelinek M, Malik M, Eaton CB, Brauer D, Cloud G, Wood EM, Mahady SE, Satterfield S, Grimm R, Murray AM; ASPREE Investigator Group. McNeil JJ, et al. N Engl J Med. 2018 Oct 18;379(16):1509-1518. doi: 10.1056/NEJMoa1805819. Epub 2018 Sep 16. N Engl J Med. 2018. PMID: 30221597 Free PMC article. Clinical Trial.

References

    1. McNeil JJ, Wolfe R, Woods RL, et al. Effect of aspirin on cardiovascular events and bleeding in the healthy elderly. N Engl J Med. 2018;379:1509–1518. - PMC - PubMed
    1. Murphy SL, Xu JQ, Kochanek KD, et al. Mortality in the United States, 2017. NCHS Data Brief, no. 328. Hyattsville, MD: National Center for Health Statistics. 2018. - PubMed
    1. Smith SC Jr, Benjamin EJ, Bonow RO, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation. 2011;124:2458–2473. - PubMed
    1. Gaziano JM, Brotons C, Coppolecchia R, et al. Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial. Lancet. 2018;392:1036–1046. - PMC - PubMed
    1. Bowman L, Mafham M, Wallendszus K, et al; ASCEND Study Collaborative Group. Effects of aspirin for primary prevention in persons with diabetes mellitus. N Engl J Med. 2018;379: 1529-1539. - PubMed

Publication types